Interrogating open issues in cancer precision medicine with patient-derived xenografts.
about
Current status and perspectives of patient-derived xenograft models in cancer research.Current Update of Patient-Derived Xenograft Model for Translational Breast Cancer Research.Mouse models of metastasis: progress and prospects.Patient-derived xenografts, a multi-faceted in vivo model enlightening research on rare liver cancer biology.Temozolomide combined with irinotecan caused regression in an adult pleomorphic rhabdomyosarcoma patient-derived orthotopic xenograft (PDOX) nude-mouse model.A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of Melanoma.Identification and Characterization of Neoantigens As Well As Respective Immune Responses in Cancer Patients.Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study.A Small Molecule Inhibitor of the β-Catenin-TCF4 Interaction Suppresses Colorectal Cancer Growth In Vitro and In Vivo.Characterization of ascites-derived tumor cells from an endometrial cancer patient.Consensus molecular subtypes of colorectal cancer are recapitulated in in vitro and in vivo models.Computational approach to discriminate human and mouse sequences in patient-derived tumour xenografts.Generation and characterisation of two D2A1 mammary cancer sublines to model spontaneous and experimental metastasis in a syngeneic BALB/c host.Identifying and Targeting Sporadic Oncogenic Genetic Aberrations in Mouse Models of Triple Negative Breast Cancer.A NF-κB signature predicts low-grade glioma prognosis: a precision medicine approach based on patient-derived stem cells.Trial watch: Immune checkpoint blockers for cancer therapy.Current status of proteomics of soft tissue sarcomas.Precision medicine needs pioneering clinical bioinformaticians.Natural Agents-Mediated Targeting of Histone Deacetylases.Pancreatic cancer heterogeneity and response to Mek inhibition.Pancreas Cancer Precision Treatment Using Avatar Mice from a Bioinformatics Perspective.Estrogens and Their Receptors in Prostate Cancer: Therapeutic Implications.Bridging the divide: preclinical research discrepancies between triple-negative breast cancer cell lines and patient tumors.Interrogating open issues in cancer medicine with patient-derived xenografts.Preclinical mouse solid tumour models: status quo, challenges and perspectives.Tumor-initiating CD49f cells are a hallmark of chemoresistant triple negative breast cancer.From Chemotherapy to Combined Targeted Therapeutics: In Vitro and in Vivo Models to Decipher Intra-tumor Heterogeneity.Tumor xenograft modeling identifies an association between TCF4 loss and breast cancer chemoresistance.Rituximab Treatment Prevents Lymphoma Onset in Gastric Cancer Patient-Derived Xenografts.Patient-derived conditionally reprogrammed cells maintain intra-tumor genetic heterogeneity.Tumor heterogeneity in small cell lung cancer defined and investigated in pre-clinical mouse models.Patient-derived organoids model treatment response of metastatic gastrointestinal cancers.Use of patient-derived xenograft mouse models in cancer research and treatment.Patient derived xenografts (PDX) predict an effective heparanase-based therapy for lung cancer.Using PDX for Preclinical Cancer Drug Discovery: The Evolving Field.Addressing the challenges of applying precision oncology.Establishing and Maintaining an Extensive Library of Patient-Derived Xenograft Models.Evaluation of anti-PD-1-based therapy against triple-negative breast cancer patient-derived xenograft tumors engrafted in humanized mouse modelsXenofilteR: computational deconvolution of mouse and human reads in tumor xenograft sequence dataModeling Endometrial Cancer: Past, Present, and Future
P2860
Q33667686-F7854AE0-89F7-405E-9EFA-313472723FC8Q38689944-1CF82766-39E8-4803-ACD2-7CB0E5FC4306Q41664785-633786A0-7506-4BEC-A925-AC377EB99945Q44236009-17127FBB-2F28-452F-9576-00B5544C061BQ46142258-D76946C1-69F9-4602-AD65-4D6F5EE32107Q47123308-BBFC01CA-9821-46FF-A654-C1DC1BCD6A15Q47133741-3A9CE9CC-3170-4881-A9A4-483E8511029EQ47137308-3A2FDDB4-FD4C-4F37-B07B-BBC7255AE531Q47145975-31198BA5-68E0-4E6C-BA19-927E2E0F3F51Q47160287-6EF6E5E6-A5F9-4E51-835D-F1BE94A7EA29Q47203432-AD180F96-A057-4CB7-BC54-2AE317497F5BQ47204651-2E744AD5-4DE6-4351-9347-6CE97EB0D3A4Q47281042-C197510A-EFAE-4840-A1D9-29DAB6C43F0EQ47285585-71989843-E2B8-44B6-A5D7-D14C392D0D39Q47307094-A95607BB-0348-416D-A5B8-6875AE66BC85Q47393365-0CE148B8-FF4E-429B-AA49-E983803E4432Q47640603-D69BF3D4-27C8-4A3D-8CE4-2CA4EF7E4CEAQ47703147-5946CBF5-F6FD-4410-AEDA-F8A96EE00542Q47740361-865650EB-062D-4D17-BC72-603383779EE9Q48328230-BF3234E3-CB77-490E-A5EA-CAFC302730E9Q48675205-31E6F945-41E3-409C-B7A8-63B02F75A817Q49208785-13784870-B9F5-413C-852D-970228CA7763Q49619782-F4BEC50F-EC7D-43FF-A442-82A2F9D923A8Q50080940-ACB25CAB-9EAB-41FA-866D-2EBDD5764F16Q50096902-7AD3D5E3-8BFD-4EFA-98C7-129D1B04129AQ50227686-58D318F0-3FD9-48EA-8A27-72A33A3A2050Q50351390-96896DD1-1F86-4288-843A-7ED3286E8FDBQ52318759-DE81FCF0-40BE-4B56-89DF-01DA0B38E49EQ52638232-E24E1A19-A405-4919-827B-5BABDB1330F4Q52671067-75BD5E50-219B-4691-9484-3190B139B2BCQ53702193-B0BE1AD4-840D-4A26-B9F6-D255E258F93EQ53707065-35BFE6A4-0773-4464-A0CE-CF13B3F13595Q54983279-7E9FA8A3-15CF-4DB3-83D4-35CD018FCFB2Q55054468-E22862AD-A905-417A-B9A5-A2DDE6C75B5AQ55148658-69C519ED-99CD-4009-A4F9-AD30E71F6E7CQ55314165-61750913-AF53-490D-81F4-03B82BA8C608Q55380373-2CB9EBCF-0571-4447-BFB7-AEB46BDAAF7CQ56889140-1AF81052-7850-47B8-BC83-C86BCE06B637Q57024703-AEEC142A-66C2-4002-96F1-A24A43E06E62Q57170070-C168889D-8EB5-4D07-A4AE-F19379B0702D
P2860
Interrogating open issues in cancer precision medicine with patient-derived xenografts.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Interrogating open issues in cancer precision medicine with patient-derived xenografts.
@en
Interrogating open issues in cancer precision medicine with patient-derived xenografts.
@nl
type
label
Interrogating open issues in cancer precision medicine with patient-derived xenografts.
@en
Interrogating open issues in cancer precision medicine with patient-derived xenografts.
@nl
prefLabel
Interrogating open issues in cancer precision medicine with patient-derived xenografts.
@en
Interrogating open issues in cancer precision medicine with patient-derived xenografts.
@nl
P2093
P50
P356
P1476
Interrogating open issues in cancer precision medicine with patient-derived xenografts
@en
P2093
Alberto Villanueva
Alejandra Bruna
Alejandro Piris-Gimenez
Andrea Bertotti
Carlos Caldas
Daniel S Peeper
David K Chang
Denis G Alférez
Dominique Vanhecke
Els Hermans
P2888
P304
P356
10.1038/NRC.2016.140
P407
P50
P577
2017-01-20T00:00:00Z